Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Technology Advances: CISH technology Facilitates Assay of HER2 Expression
Dorothy J. Schirf, MD, MDLinx Oncology
Today's Oncology News: VEGFb Designated Orphan Drug Status By FDA
D Scott Cunningham MD, PhD, MDLinx Oncology
  See all
Lung cancer Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancer
Lung Cancer, 05/16/08
Print     Email This Article     Save in My Library   Free Abstract
Katsabeki-Katsafli A et al. - In a study to determine the serum VEGF levels and oxidative stress in pts with primary lung cancer and to investigate their association with clinicopathologic factors, it was shown that oxidative stress and VEGF are significantly increased in pts with primary lung cancer

Methods
  • Serum VEGF levels and oxidative stress were measured in 63 pts with primary lung cancer before any treatment and 25 normal subjects
  • Serum VEGF levels were measured with enzyme linked immunosorbent assay
  • Serum oxidative stress levels were detected by a commercially available assay

Results
  • Levels of oxidative stress in pts were higher than those in normal subjects
  • A significant difference was found in serum VEGF levels between lung cancer pts and healthy controls
  • Serum oxidative stress presented a significant correlation with serum VEGF levels in pts with lung cancer
  • Serum VEGF levels were significantly associated with the clinical staging of the pts, performance status, and age

 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- LUNG/THORACIC ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email

Quality-of-Life Assessment for Routine Oncology Clinical Practice
The Journal of Supportive Oncology, 06/16/08

Cetuximab for advanced lung cancer
National Cancer Institute, 06/23/08

Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
Journal of Clinical Oncology, 07/23/08


Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.